HTLV-III SEROLOGY DISTINGUISHES ATYPICAL AND ENDEMIC KAPOSI'S SARCOMA IN AFRICA
- 16 February 1985
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 325 (8425), 359-361
- https://doi.org/10.1016/s0140-6736(85)91383-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- PREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAINThe Lancet, 1984
- ACQUIRED IMMUNODEFICIENCY SYNDROME IN RWANDAThe Lancet, 1984
- DETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROMEThe Lancet, 1984
- SEROEPIDEMIOLOGICAL STUDIES OF HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN ACQUIRED IMMUNODEFICIENCY SYNDROMEThe Lancet, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- AFRICAN KAPOSI'S SARCOMA AND AIDSThe Lancet, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- AIDS IN A DANISH SURGEON (ZAIRE, 1976)The Lancet, 1983
- ACQUIRED IMMUNE DEFICIENCY SYNDROME IN BLACK AFRICANSThe Lancet, 1983
- KAPOSIʼS SARCOMA IN ORGAN TRANSPLANT RECIPIENTS REPORT OF 20 CASESTransplantation, 1979